156 related articles for article (PubMed ID: 17426207)
21. Montelukast and fluticasone propionate.
Nathan R
Ann Allergy Asthma Immunol; 2003 Dec; 91(6):585; author reply 586-7. PubMed ID: 14700445
[No Abstract] [Full Text] [Related]
22. Angiopoietins 1 and 2 in sputum supernatant of optimally treated asthmatics: the effect of smoking.
Petta V; Bakakos P; Tseliou E; Kostikas K; Simoes DC; Konstantellou E; Hillas G; Koulouris NG; Papiris S; Loukides S
Eur J Clin Invest; 2015 Jan; 45(1):56-62. PubMed ID: 25402718
[TBL] [Abstract][Full Text] [Related]
23. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
[TBL] [Abstract][Full Text] [Related]
24. Adherence to asthma controller medication regimens.
Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
[TBL] [Abstract][Full Text] [Related]
25. Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma.
Feltis BN; Wignarajah D; Reid DW; Ward C; Harding R; Walters EH
Thorax; 2007 Apr; 62(4):314-9. PubMed ID: 17105777
[TBL] [Abstract][Full Text] [Related]
26. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR
J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor overexpression in induced sputum of children with bronchial asthma.
Hossny E; El-Awady H; Bakr S; Labib A
Pediatr Allergy Immunol; 2009 Feb; 20(1):89-96. PubMed ID: 18298425
[TBL] [Abstract][Full Text] [Related]
28. Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma.
Zanini A; Chetta A; Saetta M; Baraldo S; D'Ippolito R; Castagnaro A; Neri M; Olivieri D
J Allergy Clin Immunol; 2007 Aug; 120(2):329-33. PubMed ID: 17559912
[TBL] [Abstract][Full Text] [Related]
29. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma.
Feltis BN; Wignarajah D; Zheng L; Ward C; Reid D; Harding R; Walters EH
Am J Respir Crit Care Med; 2006 Jun; 173(11):1201-7. PubMed ID: 16528018
[TBL] [Abstract][Full Text] [Related]
30. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
[TBL] [Abstract][Full Text] [Related]
31. Montelukast and airway remodeling in children with chronic persistent asthma: an open study.
Pifferi M; Caramella D; Ragazzo V; De Marco E; Pietrobelli A; Boner AL
Pediatr Allergy Immunol; 2004 Oct; 15(5):472-3. PubMed ID: 15482525
[TBL] [Abstract][Full Text] [Related]
32. Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone.
Allen-Ramey FC; Markson LE; Riedel AA; Sajjan S; Weiss KB
Curr Med Res Opin; 2006 Aug; 22(8):1453-61. PubMed ID: 16870071
[TBL] [Abstract][Full Text] [Related]
33. Effect of montelukast for treatment of asthma in cigarette smokers.
Price D; Popov TA; Bjermer L; Lu S; Petrovic R; Vandormael K; Mehta A; Strus JD; Polos PG; Philip G
J Allergy Clin Immunol; 2013 Mar; 131(3):763-71. PubMed ID: 23380218
[TBL] [Abstract][Full Text] [Related]
34. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM
Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
[TBL] [Abstract][Full Text] [Related]
35. Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients.
Kanazawa H; Yoshikawa T; Hirata K; Yoshikawa J
Chest; 2004 May; 125(5):1700-5. PubMed ID: 15136379
[TBL] [Abstract][Full Text] [Related]
36. The effect of Ginkgo Biloba extract on the expression of PKCalpha in the inflammatory cells and the level of IL-5 in induced sputum of asthmatic patients.
Tang Y; Xu Y; Xiong S; Ni W; Chen S; Gao B; Ye T; Cao Y; Du C
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):375-80. PubMed ID: 17828490
[TBL] [Abstract][Full Text] [Related]
37. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
Sorkness CA; Lemanske RF; Mauger DT; Boehmer SJ; Chinchilli VM; Martinez FD; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bloomberg GR; Covar RA; Guilbert TW; Heldt G; Larsen G; Mellon MH; Morgan WJ; Moss MH; Spahn JD; Taussig LM;
J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of angiopoietin 1 and 2, vascular endothelial growth factor, and tumor necrosis factor alpha levels in asthmatic children.
Köksal BT; Ozbek OY; Bayraktar N; Yazici AC
Allergy Asthma Proc; 2014; 35(6):482-8. PubMed ID: 25584916
[TBL] [Abstract][Full Text] [Related]
39. Validity of measurement of two specific biomarkers for the assessment of small airways inflammation in asthma.
Kanazawa H; Kyoh S; Asai K; Hirata K
J Asthma; 2010 May; 47(4):400-6. PubMed ID: 20528593
[TBL] [Abstract][Full Text] [Related]
40. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
